Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(5), P. 606 - 606
Published: May 2, 2025
Inflammation
is
a
multifaceted
biological
response
of
the
immune
system
against
various
harmful
stimuli,
including
pathogens
(such
as
bacteria
and
viruses),
cellular
damage,
toxins,
natural/synthetic
irritants.
This
protective
mechanism
essential
for
eliminating
cause
injury,
removing
damaged
cells,
initiating
repair
process.
While
inflammation
fundamental
component
body’s
defense
healing
process,
its
dysregulation
can
lead
to
pathological
consequences,
contributing
acute
chronic
diseases,
such
autoimmune
disorders,
cancer,
metabolic
syndromes,
cardiovascular
neurodegenerative
conditions,
other
systemic
complications.
Generally,
non-steroidal
anti-inflammatory
drugs
(NSAIDs),
corticosteroids,
disease-modifying
anti-rheumatic
(DMARDs),
antihistamines,
biologics,
colchicine
are
used
pharmacological
agents
in
management
inflammatory
diseases.
However,
these
conventional
treatments
often
have
limitations,
adverse
side
effects,
long-term
toxicity,
drug
resistance.
In
contrast,
enzyme-based
therapeutics
emerged
promising
alternative
due
their
high
specificity,
catalytic
efficiency,
ability
modulate
pathways
with
reduced
effects.
These
enzymes
function
by
scavenging
reactive
oxygen
species
(ROS),
inhibiting
cytokine
transcription,
degrading
circulating
cytokines,
blocking
release
targeting
exocytosis-related
receptors.
Additionally,
role
tissue
regeneration
further
enhances
therapeutic
potential.
Most
natural
belong
oxidoreductase
class,
catalase
superoxide
dismutase,
well
hydrolases
trypsin,
chymotrypsin,
nattokinase,
bromelain,
papain,
serratiopeptidase,
collagenase,
hyaluronidase,
lysozyme.
Engineered
enzymes,
Tobacco
Etch
Virus
(TEV)
protease
botulinum
neurotoxin
type
A
(BoNT/A),
also
demonstrated
significant
potential
targeted
therapies.
Recent
advancements
enzyme
engineering,
nanotechnology-based
delivery,
biopharmaceutical
formulations
expanded
applicability
treating
review
provides
comprehensive
overview
both
engineered
along
formulations,
therapeutics.
It
highlights
improvements
stability,
efficacy,
minimized
immunogenicity,
while
discussing
mechanisms
action
clinical
applications
future
developments
biomedical
Journal of Hematology & Oncology,
Journal Year:
2024,
Volume and Issue:
17(1)
Published: April 2, 2024
Abstract
Cancer
immunotherapy
and
vaccine
development
have
significantly
improved
the
fight
against
cancers.
Despite
these
advancements,
challenges
remain,
particularly
in
clinical
delivery
of
immunomodulatory
compounds.
The
tumor
microenvironment
(TME),
comprising
macrophages,
fibroblasts,
immune
cells,
plays
a
crucial
role
response
modulation.
Nanoparticles,
engineered
to
reshape
TME,
shown
promising
results
enhancing
by
facilitating
targeted
These
nanoparticles
can
suppress
fibroblast
activation,
promote
M1
macrophage
polarization,
aid
dendritic
cell
maturation,
encourage
T
infiltration.
Biomimetic
further
enhance
increasing
internalization
agents
cells
such
as
cells.
Moreover,
exosomes,
whether
naturally
secreted
body
or
bioengineered,
been
explored
regulate
TME
immune-related
affect
cancer
immunotherapy.
Stimuli-responsive
nanocarriers,
activated
pH,
redox,
light
conditions,
exhibit
potential
accelerate
co-application
with
checkpoint
inhibitors
is
an
emerging
strategy
boost
anti-tumor
immunity.
With
their
ability
induce
long-term
immunity,
nanoarchitectures
are
structures
development.
This
review
underscores
critical
overcoming
current
driving
advancement
modification.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(5)
Published: Sept. 11, 2023
Abstract
Macrophages
play
diverse
roles
in
development,
homeostasis,
and
immunity.
Accordingly,
the
dysfunction
of
macrophages
is
involved
occurrence
progression
various
diseases,
such
as
coronavirus
disease
2019
atherosclerosis.
The
protective
or
pathogenic
effect
that
exert
different
conditions
largely
depends
on
their
functional
plasticity,
which
regulated
via
signal
transduction
Janus
kinase–signal
transducer
activator
transcription,
Wnt
Notch
pathways,
stimulated
by
environmental
cues.
Over
past
few
decades,
molecular
mechanisms
signaling
pathways
have
been
gradually
elucidated,
providing
more
alternative
therapeutic
targets
for
diseases
treatment.
Here,
we
provide
an
overview
basic
physiology
expound
regulatory
within
them.
We
also
address
crucial
role
pathogenesis
including
autoimmune,
neurodegenerative,
metabolic,
infectious
cancer,
with
a
focus
advances
macrophage‐targeted
strategies
exploring
modulation
components
regulators
pathways.
Last,
discuss
challenges
possible
solutions
therapy
clinical
applications.
hope
this
comprehensive
review
will
directions
further
research
targeting
macrophage
are
promising
to
improve
efficacy
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(11), P. 5723 - 5723
Published: May 24, 2024
Wound
infections
caused
by
opportunistic
bacteria
promote
persistent
infection
and
represent
the
main
cause
of
delayed
healing.
Probiotics
are
acknowledged
for
their
beneficial
effects
on
human
body
could
be
utilized
in
management
various
diseases.
They
also
possess
capacity
to
accelerate
wound
healing,
due
remarkable
anti-pathogenic,
antibiofilm,
immunomodulatory
effects.
Oral
topical
probiotic
formulations
have
shown
promising
openings
field
dermatology,
there
vitro
vivo
models
focusing
healing
mechanisms.
dressings
embedded
with
prebiotics
probiotics
now
prime
candidates
designing
therapeutic
approaches
combat
process.
The
aim
this
review
is
conduct
an
extensive
scientific
literature
regarding
efficacy
oral
management,
as
well
potential
dressing
embedding
pre-
stimulating
Cancer Cell International,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Dec. 6, 2023
Histone
chaperones
(HCs)
are
crucial
for
governing
genome
stability
and
gene
expression
in
multiple
cancers.
However,
the
functioning
of
HCs
tumor
microenvironment
(TME)
is
still
not
clearly
understood.Self-tested
single-cell
RNA-seq
data
derived
from
6
breast
cancer
(BC)
patients
with
brain
liver
metastases
were
reanalyzed
by
nonnegative
matrix
factorization
(NMF)
algorithm
36
HCs.
TME
subclusters
observed
BC
immunotherapy
public
cohorts
to
assess
their
prognosis
immune
response.
The
biological
effect
HSPA8,
one
HCs,
was
verified
transwell
assay
wound-healing
assays.Cells
including
fibroblasts,
macrophages,
B
cells,
T
classified
into
various
based
on
marker
genes.
Additionally,
it
showed
that
might
be
strongly
associated
clinical
features
metastases,
along
pseudotime
trajectory
each
cell
type.
Besides,
results
bulk-seq
analysis
revealed
mediated
distinguished
significant
prognostic
value
relevant
patients'
responses,
especially
cells
macrophages.
In
particular,
CellChat
exhibited
HCs-related
extensive
diverse
interactions
malignant
cells.
Finally,
assays
HSPA8
deficiency
inhibited
migration
invasion.Collectively,
our
study
first
dissected
HCs-guided
intercellular
communication
contribute
metastases.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9422 - 9422
Published: Aug. 30, 2024
The
gut
barrier
is
essential
for
protection
against
pathogens
and
maintaining
homeostasis.
Macrophages
are
key
players
in
the
immune
system,
indispensable
intestinal
health,
contribute
to
defense
repair
mechanisms.
Understanding
multifaceted
roles
of
macrophages
can
provide
critical
insights
into
restoring
gastrointestinal
(GI)
health.
This
review
explores
role
function
their
contribution
post-inflammatory
post-infectious
responses
gut.
significantly
integrity
through
epithelial
repair,
modulation,
interactions
with
microbiota.
They
demonstrate
active
plasticity
by
switching
phenotypes
resolve
inflammation,
facilitate
tissue
regulate
microbial
populations
following
an
infection
or
inflammation.
In
addition,
tissue-resident
(M2)
infiltration
(M1)
convert
each
other
problems
such
as
IBS
IBD
via
major
signaling
pathways
mediated
NF-κB,
JAK/STAT,
PI3K/AKT,
MAPK,
Toll-like
receptors,
specific
microRNAs
miR-155,
miR-29,
miR-146a,
miR-199,
which
may
be
good
targets
new
therapeutic
approaches.
Future
research
should
focus
on
elucidating
detailed
molecular
mechanisms
developing
personalized
approaches
fully
harness
potential
maintain
restore
permeability
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: Oct. 3, 2024
Chimeric
Antigen
Receptor
(CAR)
technology
has
revolutionized
cellular
immunotherapy,
particularly
with
the
success
of
CAR-T
cells
in
treating
hematologic
malignancies.
However,
have
limited
efficacy
against
solid
tumors.
To
address
these
limitations,
CAR-macrophages
(CAR-Ms)
leverage
innate
properties
macrophages
specificity
and
potency
CAR
technology,
offering
a
novel
promising
approach
to
cancer
immunotherapy.
Preclinical
studies
shown
that
CAR-Ms
can
effectively
target
destroy
tumor
cells,
even
within
challenging
microenvironments,
by
exhibiting
direct
cytotoxicity
enhancing
recruitment
activation
other
immune
cells.
Additionally,
favorable
safety
profile
their
persistence
tumors
position
as
potentially
safer
more
durable
therapeutic
options
compared
This
review
explores
recent
advancements
including
engineering
strategies
optimize
anti-tumor
preclinical
evidence
supporting
use.
We
also
discuss
challenges
future
directions
developing
therapies,
emphasizing
potential
revolutionize
By
harnessing
unique
macrophages,
offer
groundbreaking
overcoming
current
limitations
cell
paving
way
for
effective
sustainable
treatments.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(3), P. 385 - 385
Published: March 18, 2024
Ammodaucus
leucotrichus
exhibits
promising
pharmacological
activity,
hinting
at
anti-inflammatory
and
anti-arthritic
effects.
This
study
investigated
seed
extracts
from
using
methanol
n-hexane,
focusing
on
properties.
The
extract
outperformed
the
n-hexane
diclofenac,
a
reference
drug,
in
trypsin
inhibition
(85%
vs.
30%
64.67%
125
μg/mL).
For
inhibition,
IC50
values
were
82.97
μg/mL
(methanol),
202.70
(n-hexane),
97.04
(diclofenac).
Additionally,
surpassed
diclofenac
BSA
(bovine
serum
albumin)
denaturation
(90.4%
22.0%
51.4%
62.5
14.30
5408
42.30
Gas
chromatography-mass
spectrometry
(GC-MS)
revealed
59
58
secondary
metabolites
extracts,
respectively.
higher
therapeutic
activity
of
was
attributed
to
hydroxyacetic
acid
hydrazide,
absent
extract.
In
silico
docking
studies
identified
28
compounds
with
negative
binding
energies,
indicating
potential
inhibition.
2-hydroxyacetohydrazide
displayed
superior
inhibitory
effects
compared
diclofenac.
Further
mechanistic
are
crucial
validate
as
drug
candidate
for
rheumatoid
arthritis
treatment.
Biomedical Materials,
Journal Year:
2024,
Volume and Issue:
19(4), P. 042003 - 042003
Published: May 13, 2024
Abstract
Infectious
diseases
severely
threaten
human
health,
and
traditional
treatment
techniques
face
multiple
limitations.
As
an
important
component
of
immune
cells,
macrophages
display
unique
biological
properties,
such
as
biocompatibility,
immunocompatibility,
targeting
specificity,
immunoregulatory
activity,
play
a
critical
role
in
protecting
the
body
against
infections.
The
macrophage
membrane-coated
nanoparticles
not
only
maintain
functions
inner
but
also
inherit
characteristics
macrophages,
making
them
excellent
tools
for
improving
drug
delivery
therapeutic
implications
infectious
(IDs).
In
this
review,
we
describe
their
advantages
challenges
ID
therapy.
We
first
summarize
pathological
features
IDs,
providing
insight
into
how
to
fight
them.
Next,
focus
on
classification,
characteristics,
preparation
nanoparticles.
Finally,
comprehensively
progress
combating
including
delivery,
inhibition
killing
pathogens,
modulation.
At
end
look
forward
aspect
is
presented.